50% OFF
MarketBeat All Access
Get 30 days free. Save 50% your first year.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
×
S&P 500   3,693.23
DOW   29,590.41
QQQ   275.51
Get 1TB of Top-Rated Cloud Storage for Life for Just $112
Gold is about to SOAR – here’s what you need to do (Ad)
Germany secures more gas shipments as Scholz visits Gulf
Labour conference starts with focus on 'immoral' tax cuts
Gold is about to SOAR – here’s what you need to do (Ad)
Poverty, inflation, fear: Egypt's economy pushed to brink
Poverty and inflation: Egypt's economy hit by global turmoil
Gold is about to SOAR – here’s what you need to do (Ad)
German leader continues Gulf tour with stops in UAE, Qatar
Fire breaks out at world's biggest produce market in Paris
S&P 500   3,693.23
DOW   29,590.41
QQQ   275.51
Get 1TB of Top-Rated Cloud Storage for Life for Just $112
Gold is about to SOAR – here’s what you need to do (Ad)
Germany secures more gas shipments as Scholz visits Gulf
Labour conference starts with focus on 'immoral' tax cuts
Gold is about to SOAR – here’s what you need to do (Ad)
Poverty, inflation, fear: Egypt's economy pushed to brink
Poverty and inflation: Egypt's economy hit by global turmoil
Gold is about to SOAR – here’s what you need to do (Ad)
German leader continues Gulf tour with stops in UAE, Qatar
Fire breaks out at world's biggest produce market in Paris
S&P 500   3,693.23
DOW   29,590.41
QQQ   275.51
Get 1TB of Top-Rated Cloud Storage for Life for Just $112
Gold is about to SOAR – here’s what you need to do (Ad)
Germany secures more gas shipments as Scholz visits Gulf
Labour conference starts with focus on 'immoral' tax cuts
Gold is about to SOAR – here’s what you need to do (Ad)
Poverty, inflation, fear: Egypt's economy pushed to brink
Poverty and inflation: Egypt's economy hit by global turmoil
Gold is about to SOAR – here’s what you need to do (Ad)
German leader continues Gulf tour with stops in UAE, Qatar
Fire breaks out at world's biggest produce market in Paris
S&P 500   3,693.23
DOW   29,590.41
QQQ   275.51
Get 1TB of Top-Rated Cloud Storage for Life for Just $112
Gold is about to SOAR – here’s what you need to do (Ad)
Germany secures more gas shipments as Scholz visits Gulf
Labour conference starts with focus on 'immoral' tax cuts
Gold is about to SOAR – here’s what you need to do (Ad)
Poverty, inflation, fear: Egypt's economy pushed to brink
Poverty and inflation: Egypt's economy hit by global turmoil
Gold is about to SOAR – here’s what you need to do (Ad)
German leader continues Gulf tour with stops in UAE, Qatar
Fire breaks out at world's biggest produce market in Paris
NASDAQ:EKSO

Ekso Bionics - EKSO Stock Forecast, Price & News

$1.62
-0.10 (-5.81%)
(As of 09/23/2022 12:00 AM ET)
Add
Compare
Today's Range
$1.60
$1.73
50-Day Range
$1.62
$2.49
52-Week Range
$1.54
$4.94
Volume
21,820 shs
Average Volume
24,487 shs
Market Capitalization
$21.11 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$9.00

Ekso Bionics MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
455.6% Upside
$9.00 Price Target
Short Interest
Healthy
0.80% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.65mentions of Ekso Bionics in the last 14 days
Based on 4 Articles This Week
Insider Trading
Selling Shares
$33,944 Sold Last Quarter
Proj. Earnings Growth
Growing
From ($1.04) to ($0.54) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.16 out of 5 stars

Medical Sector

410th out of 1,075 stocks

General Industrial Machinery, Industry

3rd out of 10 stocks

EKSO stock logo

About Ekso Bionics (NASDAQ:EKSO) Stock

Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Europe, the Middle east, Africa, the Asia Pacific, and internationally. The company operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. It also provides EksoNR, a wearable bionic suit and rehabilitation device that assists physical therapists and physicians to treat patients with acquired brain injury, stroke, and spinal cord injury; and EksoUE is a wearable upper extremity assistive device that helps to reduce the effect of gravity on the wearer's shoulders and arms. Ekso Bionics Holdings, Inc. has a license agreement with Lockheed Martin Corporation. The company was incorporated in 2005 and is headquartered in Richmond, California.

Receive EKSO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ekso Bionics and its competitors with MarketBeat's FREE daily newsletter.

EKSO Stock News Headlines

Ekso Bionics Holdings, Inc. (EKSO)
Ekso Bionics (NASDAQ:EKSO) Coverage Initiated at StockNews.com
Ekso Bionics: Fragile Opportunity
Ekso Bionics Reports Second Quarter 2022 Results
SBSW, ALGN and EKSO among pre market losers
See More Headlines
Receive EKSO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ekso Bionics and its competitors with MarketBeat's FREE daily newsletter.

EKSO Company Calendar

Last Earnings
7/28/2022
Today
9/25/2022
Next Earnings (Estimated)
11/01/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
General industrial machinery,
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:EKSO
Previous Symbol
OTCMKTS:EKSOD
Employees
55
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$9.00
High Stock Price Forecast
$9.00
Low Stock Price Forecast
$9.00
Forecasted Upside/Downside
+455.6%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$-9,760,000.00
Pretax Margin
-94.39%

Debt

Sales & Book Value

Annual Sales
$11.25 million
Book Value
$2.94 per share

Miscellaneous

Free Float
12,630,000
Market Cap
$21.11 million
Optionable
Not Optionable
Beta
1.77

Key Executives

  • Mr. Steven A. Sherman (Age 76)
    Chairman & CEO
    Comp: $100k
  • Mr. Scott W. Davis (Age 52)
    Pres & COO
  • Mr. Jerome Wong (Age 48)
    Corp. Controller & Interim CFO
  • Ms. Rachael Anderson
    Global Director of Marketing & Strategic Growth
  • Mr. Anthony Pratt
    VP of Sales
  • Ms. Ann Cookson
    HR Director
  • Ms. Foon Lim Chwee
    Pres of APAC
  • Mr. Stephan Aderhold
    Sr. VP & GM of EMEA













EKSO Stock - Frequently Asked Questions

Should I buy or sell Ekso Bionics stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Ekso Bionics in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" EKSO shares.
View EKSO analyst ratings
or view top-rated stocks.

What is Ekso Bionics' stock price forecast for 2022?

1 Wall Street analysts have issued 12-month price targets for Ekso Bionics' stock. Their EKSO share price forecasts range from $9.00 to $9.00. On average, they anticipate the company's share price to reach $9.00 in the next twelve months. This suggests a possible upside of 455.6% from the stock's current price.
View analysts price targets for EKSO
or view top-rated stocks among Wall Street analysts.

How have EKSO shares performed in 2022?

Ekso Bionics' stock was trading at $2.65 at the start of the year. Since then, EKSO stock has decreased by 38.9% and is now trading at $1.62.
View the best growth stocks for 2022 here
.

When is Ekso Bionics' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 1st 2022.
View our EKSO earnings forecast
.

How were Ekso Bionics' earnings last quarter?

Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) released its quarterly earnings results on Thursday, July, 28th. The company reported ($0.23) earnings per share for the quarter, topping the consensus estimate of ($0.24) by $0.01. The company earned $3.47 million during the quarter, compared to analyst estimates of $3.49 million. Ekso Bionics had a negative trailing twelve-month return on equity of 35.11% and a negative net margin of 94.39%. During the same period in the prior year, the business earned ($0.26) EPS.

When did Ekso Bionics' stock split?

Ekso Bionics shares reverse split before market open on Thursday, May 5th 2016. The 1-7 reverse split was announced on Wednesday, May 4th 2016. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, May 4th 2016. An investor that had 100 shares of stock prior to the reverse split would have 14 shares after the split.

What other stocks do shareholders of Ekso Bionics own?
What is Ekso Bionics' stock symbol?

Ekso Bionics trades on the NASDAQ under the ticker symbol "EKSO."

Who are Ekso Bionics' major shareholders?

Ekso Bionics' stock is owned by a number of institutional and retail investors. Top institutional investors include Renaissance Technologies LLC (0.34%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include Jason C Jones, Jerome Wong, John Glenn, Scott G Davis and Steven Sherman.
View institutional ownership trends
.

How do I buy shares of Ekso Bionics?

Shares of EKSO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Ekso Bionics' stock price today?

One share of EKSO stock can currently be purchased for approximately $1.62.

How much money does Ekso Bionics make?

Ekso Bionics (NASDAQ:EKSO) has a market capitalization of $21.11 million and generates $11.25 million in revenue each year. The company earns $-9,760,000.00 in net income (profit) each year or ($0.99) on an earnings per share basis.

How can I contact Ekso Bionics?

Ekso Bionics' mailing address is 1414 HARBOUR WAY SOUTH SUITE 1201, RICHMOND CA, 94804. The official website for the company is www.eksobionics.com. The company can be reached via phone at (510) 984-1761, via email at investors@eksobionics.com, or via fax at 510-927-2647.

This page (NASDAQ:EKSO) was last updated on 9/25/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.